May 18, World AIDS Vaccine Day

May 18, World AIDS Vaccine Day.

May 18 is HIV Vaccine Awareness Day also known as World AIDS Vaccine Day—an opportunity to recognize the volunteers, community members, health professionals, and scientists involved in HIV vaccine research. It is also a time to educate communities about the importance of HIV vaccine research.

The first World AIDS Vaccine Day was observed on May 18, 1998 to commemorate the anniversary of Clinton’s speech (May 18, 1997 at Morgan State University), and the tradition continues today

HIV research includes studies underway to develop both preventive and therapeutic vaccines:

  • A preventive HIV vaccine is intended for people who do not have HIV. A safe and effective preventive HIV vaccine is key to ending the HIV/AIDS pandemic.
  • A therapeutic HIV vaccine is intended for people who have HIV. A safe and effective therapeutic HIV vaccine could prevent HIV from advancing to AIDS, replace daily use of HIV medicines, and help rid the body of HIV.

About Preventive HIV Vaccine

  • A preventive HIV vaccine is given to people who do not have HIV, with the goal of preventing HIV infection in the future.
  • There are currently no preventive HIV vaccines approved by the Food and Drug Administration (FDA), but research is under way. You must be enrolled in a clinical trial to receive a preventive HIV vaccine.

 

About Therapeutic HIV Vaccine

 

  • A therapeutic HIV vaccine is a vaccine that’s designed to improve the body’s immune response to HIV in a person who already has HIV.
  • There are currently no therapeutic HIV vaccines approved by the Food and Drug Administration (FDA -USA), but research is under way.
  • Researchers are exploring therapeutic HIV vaccines

(1) To slow down the progression of HIV infection,

(2) To eliminate the need for antiretroviral therapy (ART) while still keeping undetectable levels of HIV, and

(3) As part of a larger strategy to eliminate all HIV from the body.

 

 

Read more about SelfCare365

 

Please Share Our Post

 

 

 

Leave a reply